Marketing-authorisation holder
Biogaran
6 medicines in 1 country, as authorisation holder and marketer.
Loading…
Marketing-authorisation holder
6 medicines in 1 country, as authorisation holder and marketer.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Every medicine in the registers under its name, current ones first.
6 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| CICLOCHEM 15 MG/G CHAMPÚ1,50 Porcentaje peso/peso · Champú | Ciclopirox | Spain | Authorised | 2026 |
| DULOXETINA 30 MG CAPSULAS DURAS GASTRORRESISTENTES EFG33,678 mg · Cápsula dura gastrorresistente | Duloxetine | Spain | Authorised | 2025 |
| DULOXETINA 60 MG CAPSULAS DURAS GASTRORRESISTENTES EFG67,356 mg · Cápsula dura gastrorresistente | Duloxetine | Spain | Authorised | 2025 |
| SITAGLIPTINA BIOGARAN 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG139,04 mg · Comprimido recubierto con película | Sitagliptin | Spain | Withdrawn | 2019 |
| SITAGLIPTINA BIOGARAN 25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG34,76 mg · Comprimido recubierto con película | Sitagliptin | Spain | Withdrawn | 2019 |
| SITAGLIPTINA BIOGARAN 50 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG69,52 mg · Comprimido recubierto con película | Sitagliptin | Spain | Withdrawn | 2019 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Spain | 6 | 3 | 3 | CompaniesAll medicines |
The active substances in most of its medicines.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Report an error or request removalCorrections from the company itself are welcome.
Keep Biogaran’s medicines accurate on Prognia, see how professionals use them and answer what they ask. A 20-minute call, in English.
Book a call